Crystal structure of 2-(adamantan-1-yl)-5-(3,5-dinitrophenyl)-1,3,4-oxadiazole, C18H18N4O5

C18H18N4O5, monoclinic, P21/c (no. 14), a = 11.7553(8) Å, b = 6.4876(4) Å, c = 22.3442(15) Å, β = 91.263(7)°, V = 1703.64(19) Å3, Z=4, Rgt(F) = 0.0531, wRref(F2) = 0.1376, T = 160 K. CCDC no.: 2173380 The molecular structure is shown in the figure. Table 1 contains crystallographic data and Ta...

Full description

Saved in:
Bibliographic Details
Main Authors: Al-Wahaibi, Lamya H., Blacque, Olivier, Tiekink, Edward R. T. *, El-Emam, Ali A.
Format: Article
Published: De Gruyter 2022
Subjects:
Online Access:http://eprints.sunway.edu.my/2112/
https://doi.org/10.1515/ncrs-2022-0263
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:C18H18N4O5, monoclinic, P21/c (no. 14), a = 11.7553(8) Å, b = 6.4876(4) Å, c = 22.3442(15) Å, β = 91.263(7)°, V = 1703.64(19) Å3, Z=4, Rgt(F) = 0.0531, wRref(F2) = 0.1376, T = 160 K. CCDC no.: 2173380 The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.